Quick Answer
Cogent Biosciences, Inc. reported Total Assets of $937.61 million for fiscal year 2025.
Cogent Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $937.61M | +185.9% |
| 2024 | $327.90M | +4.6% |
| 2023 | $313.44M | +4.2% |
| 2022 | $300.81M | +29.6% |
| 2021 | $232.09M | -7.5% |
| 2020 | $250.92M | +407.7% |
| 2019 | $49.42M | -42.5% |
| 2018 | $85.93M | +75.0% |
| 2017 | $49.12M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $425.93M | +10.9% | +55.0% |
| June 30, 2025 | $274.82M | -36.1% | -3.2% |
| March 31, 2025 | $283.80M | -40.4% | -13.4% |
| December 31, 2024 | $327.90M | +4.6% | -14.6% |
| September 30, 2024 | $384.02M | +8.0% | -10.7% |
| June 30, 2024 | $429.94M | +9.6% | -9.7% |
| March 31, 2024 | $476.11M | +80.9% | +51.9% |
| December 31, 2023 | $313.44M | +4.2% | -11.8% |
- Cogent Biosciences, Inc. showed an increase of +185.9% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Cogent Biosciences, Inc.’s total assets has grown by 1809.0% (from $49.12 million to $937.61 million).
- The most recent figure is from Cogent Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: